8-K/A: Two Hands Corporation Amends Filing to Include CFO Appointment

Sentiment:

Amendment to Current Report


Two Hands Corporation has amended its previous filing to include the appointment of Andrew Kucharchuk as Chief Financial Officer, following a clerical error.

Summary

  • Two Hands Corporation filed an amendment to its previous 8-K report to include the appointment of Andrew Kucharchuk as Chief Financial Officer.
  • The original filing on January 10, 2025, had omitted this appointment due to a clerical error.
  • Emil Assentato resigned as CFO on January 3, 2025, and Andrew Kucharchuk was appointed to fill the role on the same day.
  • Emil Assentato will continue to serve as CEO, President, Treasurer, Secretary, and a member of the Board of Directors.
  • Andrew Kucharchuk and Craig Marshak were also appointed as members of the Board of Directors on January 3, 2025.
  • The Board of Directors now consists of Emil Assentato, Andrew Kucharchuk, and Craig Marshak.

Sentiment

Score: 7

Explanation: The document is primarily factual, detailing changes in personnel. The correction of a clerical error is a minor negative, but the appointments of experienced individuals are positive. Overall, the sentiment is neutral to slightly positive.

Positives

  • The company has quickly filled the CFO vacancy with an experienced professional.
  • The board has been expanded with the addition of two new members with significant experience.

Negatives

  • The initial filing omitted the appointment of the new CFO, indicating a clerical error.

Risks

  • The company had a clerical error in its initial filing, which could raise concerns about internal controls.
  • The rapid change in CFO could create some short-term instability.

Management Comments

  • Emil Assentato's resignation as CFO was not due to any disagreement with the company's operations, policies, or practices.

Industry Context

The appointment of a new CFO and board members is a common occurrence in corporate governance, and the backgrounds of the appointees suggest a focus on financial expertise and strategic growth.

Comparison to Industry Standards

  • The appointment of a new CFO and board members is a standard practice in corporate governance.
  • The backgrounds of the appointees, particularly Andrew Kucharchuk's experience as a CFO and COO, and Craig Marshak's experience in investment banking and venture capital, are typical of individuals appointed to similar roles in comparable companies.
  • The restructuring experience of Craig Marshak is similar to that of advisors at companies such as AlixPartners and Alvarez & Marsal.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerEmil AssentatoAndrew Kucharchuk2025-01-03Resignation of previous CFO
Member of the Board of DirectorsN/AAndrew Kucharchuk2025-01-03Board expansion
Member of the Board of DirectorsN/ACraig Marshak2025-01-03Board expansion

Stakeholder Impact

  • Shareholders may view the appointment of a new CFO and board members as a positive step for the company.
  • Employees may experience some changes in leadership and reporting structures.

Key Dates

DateDescription
2020-07-07Andrew Kucharchuk became a director of Adhera Therapeutics Inc.
2020-09-30Andrew Kucharchuk became Chief Operating Officer of Adhera Therapeutics Inc.
2021-03-01Craig Marshak joined Clear Think Capital as a Managing Director.
2022-07-07Andrew Kucharchuk became a director of Adhera Therapeutics Inc.
2022-09-30Andrew Kucharchuk became Chief Operating Officer of Adhera Therapeutics Inc.
2025-01-03Emil Assentato resigned as CFO, Andrew Kucharchuk was appointed CFO, and Andrew Kucharchuk and Craig Marshak were appointed to the Board of Directors.
2025-01-10Original Form 8-K filing date.
2025-01-24Date of the amended Form 8-K/A filing.

Keywords

Chief Financial Officer, Board of Directors, CFO, corporate governance, executive appointment, amendment, 8-K

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.